improving Oncology exploration with Integrated KRAS Assay products and services and RAS Assays
from the swiftly evolving area of oncology exploration, exact and efficient mutation screening is critical for building specific therapies. The KRAS expert services System plays a pivotal function During this landscape by offering detailed methods for KRAS mutation profiling and analysis. KRAS mutations, present in about ninety five% of RAS-associa